NATICK, Mass., March 24, 2011 /PRNewswire/ — Boston Scientific
BSX) today announced U.S. Food and Drug Administration (FDA)
approval and U.S. launch of the Clik™ Anchor for its
Precision Plus™ Spinal Cord Stimulator (SCS) System, the
world’s first rechargeable SCS device for chronic pain management.
The Clik Anchor features an innovative locking system
designed to improve lead anchoring speed and consistency.
Locking into place on the lead with a simple turn of a hex
wrench, it provides tactile and audible confirmation for physicians
that the lead is secured. The Company is introducing the Clik
Anchor at the American Academy of Pain Medicine Annual Meeting,
which begins today in Washington, D.C.
“The Clik Anchor is easy to use and gives me confidence that the
lead is secure,” said Salim Hayek, M.D., Ph.D., of the University
Hospitals Case Medical Center in Cleveland, Ohio. “This new
product will benefit my patients and my practice with simpler, more
consistent lead anchoring.”
According to the National Center for Health Statistics, pain is
the most common reason Americans seek medical treatment, and an
estimated 26 million Americans experience frequent back pain.
Tens of thousands of patients with chronic pain have found
that SCS systems help them manage their pain. Spinal Cord
Stimulation is a reversible therapy that manages pain through an
implantable pulse generator and external devices that control
therapy and charge an implant.
Boston Scientific’s Precision Plus SCS System, powered by
SmoothWave™ Technology, masks pain signals by delivering
independently controlled pulses of electricity through SCS leads.
Anchors are designed to secure leads and minimize unwanted
“With approval and launch of the Clik Anchor, we have added six
new products to our Neuromod